Israel Englander Spero Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 147,872 shares of SPRO stock, worth $192,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

147,872

Previous 148,857 0.66%

Holding current value

$192,233

Previous $218,000 16.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.35 - $1.79 $1,329 - $1,763	-985 Reduced 0.66%	147,872 $254,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.47 $224,993 - $330,739	-224,993 Reduced 60.18%	148,857 $218,000
Q2 2023 Aug 14, 2023	SELL	$1.42 - $1.95 $171,381 - $235,347	-120,691 Reduced 24.4%	373,850 $542,000
Q1 2023 May 15, 2023	SELL	$1.35 - $2.0 $515,506 - $763,714	-381,857 Reduced 43.57%	494,541 $717,000
Q4 2022 Feb 14, 2023	BUY	$1.55 - $2.12 $291,403 - $398,564	188,002 Added 27.31%	876,398 $1.52 Million

Q3 2022 Nov 14, 2022	BUY	$0.68 - $2.2 $254,152 - $822,256	373,753 Added 118.79%	688,396 $1.38 Million
Q2 2022 Aug 15, 2022	BUY	$0.74 - $7.44 $187,502 - $1.89 Million	253,382 Added 413.61%	314,643 $233,000
Q1 2022 May 16, 2022	BUY	$7.87 - $15.15 $482,124 - $928,104	61,261 New	61,261 $533,000
Q2 2021 Aug 16, 2021	SELL	$12.22 - $15.79 $154,399 - $199,506	-12,635 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.23 - $21.48 $600,999 - $975,771	-45,427 Reduced 78.24%	12,635 $186,000
Q4 2020 Feb 16, 2021	SELL	$11.65 - $22.07 $844,764 - $1.6 Million	-72,512 Reduced 55.53%	58,062 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$8.96 - $14.12 $847,445 - $1.34 Million	94,581 Added 262.78%	130,574 $1.46 Million
Q2 2020 Aug 14, 2020	BUY	$7.27 - $14.18 $159,489 - $311,080	21,938 Added 156.09%	35,993 $487,000
Q1 2020 May 14, 2020	BUY	$5.27 - $10.41 $7,235 - $14,292	1,373 Added 10.83%	14,055 $114,000
Q4 2019 Feb 14, 2020	BUY	$9.46 - $12.16 $119,971 - $154,213	12,682 New	12,682 $122,000
Q2 2018 Aug 14, 2018	SELL	$10.41 - $17.85 $118,830 - $203,757	-11,415 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.96 - $14.61 $113,693 - $166,773	11,415 New	11,415 $163,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

15.4M

Call Options Held

19.6K

Put Options Held

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $45.6M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account